Thomas, Deborah A <br/><br/>
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.  [electronic resource] 

 -  Cancer  Apr 2006 
 - 1569-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.21776  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Burkitt Lymphoma--drug therapy<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Immunotherapy<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Rituximab<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage